1,25-Dihydroxyvitamin d3 potentiates the cytotoxic effect of TNF on human breast cancer cells

This publication has 15 references indexed in Scilit:

• 1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells
  Molecular and Cellular Endocrinology, 1993
• Cytokine-Stimulated Human Dermal Microvascular Endothelial Cells Produce Interleukin6 - Inhibition by Hydrocortisone, Dexamethasone, and Calcitriol
  Journal of Investigative Dermatology, 1992
• Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases
  Cancer, 1992
• Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
  FEBS Letters, 1991
• Topical calcipotriol treatment in advanced breast cancer
  The Lancet, 1991
• Tumor necrosis factor‐alpha induces vitamin D‐1‐hydroxylase activity in normal human alveolar macrophages
  Journal of Cellular Physiology, 1990
• Induction of manganese superoxide dismutase by tumor necrosis factor in human breast cancer MCF-7 cell line and its TNF-resistant variant
  Biochemical and Biophysical Research Communications, 1989
• POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION
  The Lancet, 1989
• The immunobiology ofvitamin D: William F.C. Rigby
  Immunology Today, 1988
• γ-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages
  Biochemical and Biophysical Research Communications, 1985